STEMLINE THERAPEUTICS
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline’s lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I human trial. Behind its lead, Stemline is developing a ... broad portfolio of compounds directed at this and other high value cancer stem cell targets of a variety of hematological and solid cancers. In addition, Stemline has built a robust discovery platform called “StemScreen®†which the Company has utilized to identify multiple compounds that target and impair cancer stem cells. Stemline also possesses a comprehensive intellectual property portfolio that includes the earliest filings in the cancer stem cell field covering cancer stem cell-directed therapeutics, diagnostics, and drug screening.
STEMLINE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Oncology
Founded:
2003-08-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.stemline.com
Total Employee:
11+
Status:
Active
Contact:
646-502-2311
Email Addresses:
[email protected]
Total Funding:
195.09 M USD
Technology used in webpage:
Domain Not Resolving SPF Amazon HSTS IPv6 Google Apps For Business Microsoft Azure DNS Common Name Invalid GoDaddy DNS AWS Global Accelerator
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Avrobio
Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Biohaven Pharmaceutical
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Cleveland Diagnostics
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pequot Capital
Pequot Capital investment in Series A - Stemline Therapeutics
Official Site Inspections
http://www.stemline.com Semrush global rank: 3.29 M Semrush visits lastest month: 4.29 K
- Host name: cloudproxy10040.sucuri.net
- IP address: 192.124.249.40
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Stemline Therapeutics"
About Us - Stemline Therapeutics
Stemline Therapeutics, a part of the Menarini Group, is focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to …See details»
Management - Stemline Therapeutics
Mr. Gionco is the Senior Vice President, Financial and Chief Accounting Officer at Stemline Therapeutics. Mr. Gionco was previously Vice President, Chief Financial Officer, and Chief Accounting Officer at Savient Pharmaceuticals, Inc., where …See details»
Menarini Stemline - LinkedIn
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on ...See details»
Stemline Therapeutics, Inc., a Menarini Group Company
Stemline is committed to applying our scientific leadership to transform the lives of people with cancer. Stemline Therapeutics is continuing to invest in research and conduct clinical trials to …See details»
Stemline Therapeutics - Crunchbase Company Profile …
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline’s lead compound, SL-401, targets the interleukin-3 …See details»
Menarini Group Completes Acquisition of Stemline …
Jun 10, 2020 Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its …See details»
Menarini Group to Acquire Stemline Therapeutics in …
Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its …See details»
Stemline Therapeutics, a subsidiary of Menarini Group, …
In ER+, HER2- Advanced or Metastatic Breast Cancer ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers. ESR1 mutations are a known driver of resistance to standard endocrine …See details»
Stemline Therapeutics to be Acquired by Menarini Group
May 4, 2020 FLORENCE, Italy and NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) -- Menarini Group, a privately held Italian pharmaceutical and diagnostics company, and …See details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
Stemline launched ELZONRIS for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adult and pediatric patients, two years or older, following the approval by the …See details»
Company Overview - Stemline Therapeutics
Stemline Therapeutics is a society of the Menarini Group. Privacy Preference Center. Privacy PreferencesSee details»
Dr. Ivan Bergstein, M.D. - Regenerative Medicine Now
Dr. Bergstein is Chief Executive Officer and Founder of Stemline Therapeutics. He led Stemline through multiple private financings and ultimately its successful IPO and subsequent follow-on …See details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
May 4, 2020 A further description of risks and uncertainties relating to Stemline can be found in Stemline’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and in …See details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
Nov 22, 2018 Menarini Group and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel …See details»
The Menarini Group Announces ELZONRIS - Business Wire
Aug 30, 2023 Stemline Therapeutics, Inc. (“Stemline”) a wholly-owned subsidiary of the Menarini Group, is a commercial-stage biopharmaceutical company focused on the development and …See details»
Menarini Makes Big US Oncology Move with Stemline Acquisition
Jun 18, 2020 The acquisition of Stemline, a commercial-stage firm working on the development and commercialisation of novel oncology therapeutics, will establish a footprint for Menarini in …See details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
May 4, 2020 Menarini Group, a privately held Italian pharmaceutical and diagnostics company, and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on …See details»
Stemline Therapeutics - Overview, News & Similar companies
Jan 31, 2023 View Stemline Therapeutics (www.stemline.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Expanded Access - Stemline Therapeutics
Menarini-Stemline is committed to developing new therapies to address the unmet medical needs of patients suffering from rare and seriously debilitating diseases. We currently have late stage …See details»